Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines. Academic Article uri icon

Overview

MeSH

  • Animals
  • Chondroitin Sulfates
  • Erythrocytes
  • Female
  • Host-Parasite Interactions
  • Humans
  • Placenta
  • Protozoan Proteins

MeSH Major

  • Malaria Vaccines
  • Malaria, Falciparum
  • Plasmodium falciparum
  • Pregnancy

abstract

  • Aided by the Plasmodium falciparum genome project, recent discoveries regarding the molecular basis of malaria pathogenesis have led to a better understanding of the interactions between host and parasite. Although vaccines that prevent infection by malaria parasites remain only hopes for the future, there are now more immediate prospects for vaccines that protect against specific disease syndromes. Here, we discuss the latest advances in the development of a vaccine that specifically targets pregnancy-associated malaria (PAM).

publication date

  • November 1, 2004

has subject area

  • Animals
  • Chondroitin Sulfates
  • Erythrocytes
  • Female
  • Host-Parasite Interactions
  • Humans
  • Malaria Vaccines
  • Malaria, Falciparum
  • Placenta
  • Plasmodium falciparum
  • Pregnancy
  • Protozoan Proteins

Research

keywords

  • Journal Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2211864

Digital Object Identifier (DOI)

  • 10.1084/jem.20041974

PubMed ID

  • 15520241

Additional Document Info

start page

  • 1093

end page

  • 1097

volume

  • 200

number

  • 9